Transitional Year·Hudson, FL

HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Bayonet Point Hospital

Signal lift21%43%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
235–258
p10 – p90
Sample N
591
applicants this cycle
This cycle
no tracked aways yet
Match rate
2.0%
12 of 113 applicants
01Cohort funnelthis cycle
N = 591
Applied
591
100.0%
Invited
113
19.1%
Class size
12
2%
J-1 visaPreliminary
Your fitHCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Bayonet Point Hospital Program

Create a free profile to see your personalized fit

Get started
Contact
FG
Program Director
Francia Guerrero, MD
Email director
AR
Program Coordinator
Ashley Resto, MD
Email coordinator
Training sites3 hospitals · Hudson
  • 1
    HCA Florida Bayonet Point Hospital
    Hudson, FL
    Primary
  • 2
    HCA Florida Healthcare/USF Morsani College of Medicine GME
    Tampa, FL
    Sponsor
  • 3
    Robert Young MD-Internal Medicine Office
    Hudson, FL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK235258
180205230255280
COMLEX Level 2 CE466654
400500600700800
Interview rates
US MD
18%
US DO
26%
US IMG
14%
Non-US IMG
4%
Applicant origin
In-state
42%
Out-of-state
14%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Bayonet Point Hospital to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.